2,4-diaminobutyric acid has been researched along with Glioblastoma in 1 studies
2,4-diaminobutyric acid: RN given refers to parent cpd without isomeric designation
2,4-diaminobutyric acid : A diamino acid that is butyric acid in which a hydrogen at position 2 and a hydrogen at position 4 are replaced by amino groups.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergenheim, AT | 1 |
| Roslin, M | 1 |
| Ungerstedt, U | 1 |
| Waldenström, A | 1 |
| Henriksson, R | 1 |
| Ronquist, G | 1 |
1 trial available for 2,4-diaminobutyric acid and Glioblastoma
| Article | Year |
|---|---|
Metabolic manipulation of glioblastoma in vivo by retrograde microdialysis of L-2, 4 diaminobutyric acid (DAB).
Topics: Aged; Aminobutyrates; Antimetabolites, Antineoplastic; Brain Neoplasms; Catheters, Indwelling; Dose- | 2006 |